Systematic mapping of antibiotic cross-resistance and collateral sensitivity with chemical genetics
Authors:
- Nazgul SakenovaNSNazgul Sakenova
- Elisabetta CacaceECElisabetta Cacace
- Askarbek OrakovAOAskarbek Orakov
- Florian HuberFHFlorian Huber
- Vallo VarikVVVallo Varik
- George KritikosGKGeorge Kritikos
- Jan MichielsJMJan Michiels
- Peer BorkPBPeer Bork
- Pascale CossartPCPascale Cossart
- Camille GoemansCGCamille Goemans
- Athanasios TypasATAthanasios Typas
Preprint
Abstract
By acquiring or evolving resistance to one antibiotic, bacteria can become resistant to a second one, due to shared underlying mechanisms. This is called cross-resistance (XR) and further limits therapeutic choices. The opposite scenario, in which initial resistance leads to sensitivity to a second antibiotic, is termed collateral sensitivity (CS) and can inform cycling or combinatorial treatments. Despite their clinical relevance, our current knowledge of such interactions is limited, mostly due to experimental constraints in their assessment and lack of understanding of the underlying mechanisms. To fill this gap, we used published chemical genetic data on the impact of all Escherichia coli non-essential genes on resistance/sensitivity to 40 antibiotics, and devised a metric that robustly discriminates between known XR and CS antibiotic interactions. This metric, based on chemical genetic profile (dis)similarity between two drugs, allowed us to infer 404 XR and 267 CS interactions, thereby expanding the number of known interactions by more than 3-fold – including reclassifying 116 previously reported interactions. We benchmarked our results by validating 55 out of 59 inferred interactions via experimental evolution. By identifying mutants driving XR and CS interactions in chemical genetics, we recapitulated known and uncovered previously unknown mechanisms, and demonstrated that a given drug pair can exhibit both interactions depending on the resistance mechanism. Finally, we applied CS drug pairs in combination to reduce antibiotic resistance development in vitro. Altogether, our approach provides a systematic framework to map XR/CS interactions and their mechanisms, paving the way for the development of rationally-designed antibiotic combination treatments.Keywords
All Related Versions
- Published version: Nature Microbiology, 10 (1), 202.
This publication has 85 references indexed in Scilit:
- Randomly barcoded transposon mutant libraries for gut commensals I: Strategies for efficient library constructionCell Reports, 2023
- Randomly barcoded transposon mutant libraries for gut commensals II: Applying libraries for functional geneticsCell Reports, 2023
- Functional genetics of human gut commensal Bacteroides thetaiotaomicron reveals metabolic requirements for growth across environmentsCell Reports, 2021
- MarR family proteins are important regulators of clinically relevant antibiotic resistanceProtein Science, 2019
- Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic InfectionsCell, 2018
- A Comprehensive, CRISPR-based Functional Analysis of Essential Genes in BacteriaCell, 2016
- Modification of Salmonella Lipopolysaccharides Prevents the Outer Membrane Penetration of NovobiocinBiophysical Journal, 2015
- Identification of Mutations in Laboratory-Evolved Microbes from Next-Generation Sequencing Data Using breseq2014
- Phenotypic Landscape of a Bacterial CellCell, 2011
- E. coli Genome Manipulation by P1 TransductionCurrent Protocols in Molecular Biology, 2007